C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms

Patents for C07D 319 - Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms (10,283)
12/2004
12/02/2004	US20040242654 Diaryl ether derivative, addition salt thereof, and immunosuppressant
12/02/2004	CA2526497A1 Catalytic composition and process for asymmetric hydrogenation
12/01/2004	EP1482018A1 Aldehydes with difluorooxymethylene bridges
12/01/2004	EP1481974A1 Fragrances based on cyclic acetals
12/01/2004	EP1480943A2 Synthesis of 3,5-dihydroxy-7-pyrrol-1-yl heptanoic acids
12/01/2004	EP1480941A2 Urea derivatives as hiv aspartyl protease inhibitors
12/01/2004	EP1055671B1 A process for producing a simvastatin precursor
12/01/2004	CN1550491A Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
12/01/2004	CN1177814C Method for preparing trion-bis (oxime ether) derivs. and trion-mono and trio-bis (oxmide ether) derivs. obtained therewith
11/2004
11/30/2004	US6825185 Improving the cardiovascular profile of a cox-2 selective inhibitor by administering with 3-hydroxy-3- methylglutaryl coenzyme a, an antiplatelet agent, a thrombin inhibitor or a thromboxane inhibitor
11/25/2004	WO2004101483A1 Novel trisubstituted benzene derivative, process for producing the same and medical drug composition containing the derivative
11/25/2004	US20040236102 Enzyme inhibitor for treating a non-insulin dependent diabetes mellitus; 3-Amino-4-(3,4-difluorophenyl)butanoyl]-4-[2-({3-[(methylsulfonyl)amino]-phenyl}-amino)-2-oxoethyl]piperazin-2-yl}acetic acid
11/25/2004	US20040235921 6-substituted 2,3-dihydro-1,4-benzodioxine, 2-position substituted with carboxy, or (C1 C6)alkoxycarbonyl; diabetes, obesity; 6-[2-(R)-[2-(S)-hydroxy-3-(4-hydroxy-3-methanesulfonamido-phenoxy)propylamino]propyl]-2,3-dihydro-1,4-benzodioxine-2-(R)-carboxylic acid; B3 andrenergic receptor agonist
11/25/2004	US20040235877 Novel use of tricyclic compound
11/25/2004	US20040235825 Administering compounds such as N-[4-[2-[2-(1-naphthyl)propanoylamino]phenyl]butanoyl]-(3,5-dimethylisoxazol-4-yl)sulfonamide for prophylaxis and therapy of pain, allodynia, hyperalgesia, pruritus, urticaria, atopic dermatitis, contact dermatitis, allergic conjunctivitis, asthma, rhinitis, sneeze
11/24/2004	EP1478632A1 Substituted aryl alkenoic acid heterocyclic amides possessing pungent taste
11/24/2004	EP1318976B1 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
11/24/2004	CN1176646C Photo-stable cosmetic and pharmaceutical formulations containing UV-filters
11/23/2004	US6822062 Supported group 8-10 transition metal olefin polymerization catalysts
11/23/2004	US6821960 Glucagon antagonists/inverse agonists
11/23/2004	US6821582 Positive dielectric anisotropy
11/18/2004	WO2004099173A1 Multivalent inhibitors of serum amyloid p component
11/18/2004	US20040230063 Process for the preparation of monoketals of 1,4-cyclohexanedione including 1, 4-cyclohexanedione mono-2,2-dimethyl trimethylene ketal
11/18/2004	US20040230056 Process for synthesizing N-aryl piperazines with chiral N'-1-[benzoyl(2-pyridyl)amino]-2-propane substitution
11/18/2004	CA2525302A1 Multivalent inhibitors of serum amyloid p component
11/17/2004	EP1477484A1 Oxonol dye compound, optical information recording medium using the same, and optical information
11/17/2004	EP1060175B1 Tryptase inhibitors
11/17/2004	EP1042276B1 Thiourea compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
11/17/2004	CN1176085C One pot recovery of D,L-lactide from D.L-lactide recrystallization residual liquid
11/16/2004	US6818779 Thromboxane ligands without blood clotting side effects
11/11/2004	WO2004052919A3 Peptide deformylase inhibitors
11/11/2004	US20040224993 Diphenylurea compounds
11/10/2004	EP1104415B1 Method of manufacture of 1,3-oxathiolane nucleosides
11/10/2004	EP1027043B1 Benzodioxole, benzofuran, dihydrobenzofuran, and benzodioxane melatonergic agents
11/10/2004	CN1545502A Process for the preparation of indole derivatives
11/10/2004	CN1174955C 3-amino-2-benzyl-1-phenyl-propane derivs.
11/10/2004	CN1174953C Process for producing purified lactic acid solution
11/04/2004	WO2004080377A3 Kcnq channel modulating compounds and their pharmaceutical use
11/04/2004	US20040220193 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
11/03/2004	CN1541993A Process for continuously preparing acetals of alpha, beta-dicarbonyl compounds
11/03/2004	CN1173913C Method of using easy removed nitroxyl selective alcohol axide
11/02/2004	US6812250 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
10/2004
10/28/2004	WO2004092106A2 Process for preparing alkoxy- and aryloxy-phenols
10/28/2004	WO2004080379A3 Extract of pangium edule and lignanes which can be used as a cathepsin inhibitor or having an antinecrotic effect
10/28/2004	US20040214890 1,3-diamino-2-hydroxypropane derivatives are useful as inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal
10/28/2004	US20040214881 Method for producing optically active halopropanediol derivative
10/27/2004	EP1272456B1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/27/2004	EP1246791B1 Aminomethyl-phenyl-cyclohexanone derivatives
10/27/2004	CN1541211A Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same
10/27/2004	CN1541096A Compounds which mimic chemical and biological properties of discodermolide
10/26/2004	US6809113 For therapy of arthritis, asthma, atherosclerosis, diabetic nephropathy, inflammatory bowel disease, crohn's disease, multiple sclerosis, nephritis, pancreatitis, pulmonary fibrosis, psoriasis, restenosis transplant rejection
10/21/2004	WO2004089927A1 Novel methods for the treatment of inflammatory diseases
10/21/2004	CA2521606A1 Novel methods for the treatment of inflammatory diseases
10/20/2004	CN1538954A Protected 3,5-dihydroxy-2, 2-dimethyl-valeronitriles for synthesis of epothilones and derivatives and method for preparaton and use thereof
10/20/2004	CN1538952A Protected 3,5-dihydroxy-2, 2-dimethyl-valeroamides for synthesis of epothilone and derivatives and method for production and use thereof
10/19/2004	US6806375 Process for the production of purine derivatives and intermediates therefor
10/13/2004	EP1466892A1 Novel indanylidene compounds
10/13/2004	EP1466888A1 Calcium receptor-active arylalkyl amines
10/13/2004	EP1466625A1 Preventives/remedies for urinary disturbance
10/13/2004	CN1170616C Treating method for waste gas containing dipyryl and inhibiting composite catalyst composition produced by dipyryl
10/12/2004	US6803340 Catalyst for removing dioxin and preparation method thereof
10/07/2004	WO2004046105A3 Synthesis of 3,5-dihydroxy-7-pyrrol-1-yl heptanoic acids
10/06/2004	EP1463726A2 Aromatic thioether liver x-receptor modulators
10/06/2004	EP1463715A1 Novel glucagon antagonists
10/06/2004	EP1463714A2 Vanilloid receptor ligands and their use in treatments
10/06/2004	EP1080082B1 Intermediates for the synthesis of epothilones and methods for their preparation
10/06/2004	EP0912544B1 Process for preparing 2-substituted but-2-ene-1,4-dial-acetals and novel hemiacetals of glyoxalmonoacetals
10/06/2004	CN1534016A Calcium acceptor active compound
10/05/2004	US6800767 Method for purifying cyclic esters
10/05/2004	US6800656 Tricyclic compounds and method of treating herpes virus
09/2004
09/30/2004	WO2004083153A1 Process for manufacture of an allyl ether
09/30/2004	US20040192867 Photoresists; radiation transparent
09/30/2004	DE10312562A1 Verfahren zur kontinuierlichen Herstellung von Acetalen von α,β-Dicarbonylverbindungen Process for the continuous preparation of acetals of α, β-dicarbonyl compounds
09/29/2004	EP1461331A1 Process for the preparation of 2-(6-substituted-1,3-dioxane-4-yl) acetic acid derivatives
09/29/2004	CN1168434C Cosmetic and pharmaceutical preparations containing photostable UV filters
09/28/2004	US6797731 Resorcinol derivatives
09/28/2004	US6797726 N-alkoxyalkyl-N,N-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same
09/23/2004	WO2004080947A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient
09/23/2004	WO2004080379A2 Extract of pangium edule and lignanes which can be used as a cathepsin inhibitor or having an antinecrotic effect
09/23/2004	WO2004080377A2 Kcnq channel modulating compounds and their pharmaceutical use
09/23/2004	WO2004050613A3 2-substituted-3-propenamide derivatives and methods of using the same
09/23/2004	US20040186304 via industrial scale countercurrent thin film evaporator which reacts ketones with alcohols
09/23/2004	US20040186165 action similar to Taxol but it is active against Taxol-resistant cell lines and it is more water soluble; anticarcinogenic
09/23/2004	CA2518986A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient
09/22/2004	EP1460052A1 Process for the continuous preparation of acetals of alpha,beta-dicarbonyl compounds
09/22/2004	EP1458704A1 Aminoindane derivatives as serotonin and norepinephrine uptake inhibitors
09/22/2004	EP1458675A1 Alpha-cyanoacrylates
09/22/2004	EP1377566B1 Glycolide production process, and glycolic acid oligomer for glycolide production
09/22/2004	CN1530364A Method for preserving cyclic condensed formol
09/21/2004	US6794534 Synthesis of functionalized and unfunctionalized olefins via cross and ring-closing metathesis
09/21/2004	CA2116973C Improved process for the synthesis of (5r)-1,1-dimethylethyl 6-cyano-5-hydroxy-3-oxo-hexanoate
09/16/2004	WO2004078144A2 Diphenylethylene compounds and uses thereof
09/16/2004	US20040180838 Effective against trypanosoma brucei rhodiense and leishmania donovani
09/16/2004	CA2517886A1 Diphenylethylene compounds and uses thereof
09/15/2004	EP1456195A1 Method of making trimethylene carbonate
09/15/2004	EP1456194A1 Method of making trimethylene carbonate
09/15/2004	EP1341746B1 Liquid crystalline compounds
09/15/2004	EP1181263B1 Treatment of a composition comprising a trimethylolalkane bis-monolinear formal
09/15/2004	EP1012148B1 Monoacetals of bicyclohexyl-4,4-dione and their use in preparing liquid crystals
09/15/2004	EP0986384A4 Inhibitors of protein isoprenyl transferases

1 ... 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 ... 103